Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
NEW YORK, Sept. 19 /PRNewswire/ -- Aerolase, the manufacturer of medical aesthetic lasers, announced today that it has retained SMH Capital Inc., a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG - News), as its financial advisor to explore financing alternatives to fund expansion into new markets.
The additional funding will be primarily directed toward expanding the Aerolase sales channel expansion into the market of about 300,000 U.S. primary care practitioners. This physician group is actively adding medical aesthetics to their practices to serve continuing strong demand for cosmetic-rejuvenation procedures, especially from affluent baby boomers.
NBC Television, May 24, 2008
Featuring the LightPod Neo
"Safe Treatment of Ethnic Skin with the LightPod Neo by Fran Cook-Bolden, MD"
Courtesy of NBC, Al Roker Entertainment and the Women's Dermatological Society Foundation
The LightPod Neo™ is the safest and most versatile aesthetic laser available for the treatment of ethnic skin, as demonstrated in the video by Fran Cook-Bolden, MD. The laser employs its unique MicroPulse-1064™ technology which delivers the energy through the skin 30-50 times faster than conventional 1064nm lasers. This enables safe and pain-free treatment of even the darkest skin tone, without requiring any skin cooling during treatment. The Neo leads the industry in terms of avoiding treatment discomfort and minimizing the chances of pigmentary side-effects when dealing with ethnic skin.
For additional information on how you can purchase or lease LightPod® medical aesthetic lasers from Aerolase, please fill out our Information Request form.
Top of Page
